SCHEMBL16539999

SCHEMBL16539999

OC1C2CCC(C2)C(O)C1O

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
APP P05067 1/20 0.39
CYP2C9 P11712 1/20 0.37
GSR P00390 2/20 0.33
CA2 P00918 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127898 0.96
SCHEMBL10035514 0.96
SCHEMBL278804 0.96
SCHEMBL26258402 0.96
SCHEMBL1127899 0.96
SCHEMBL15973517 0.85 CYP2C9 (0.53) CYP2C9GSRCA2
SCHEMBL17491564 0.83 CYP2C9 (0.32) CYP2C9GSRCA2
SCHEMBL771200 0.74 CYP2C9 (0.35) CYP2C9
SCHEMBL24477655 0.74
SCHEMBL1866669 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4178970-A1 METHOD FOR PREPARING GLUCOPYRANOSYL DERIVATIVES AND INTERMEDIATES THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2023-05-17 EP disclosed
WO-2015027963-A1 AROMATIC RING DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 四川海思科制药有限公司 (CN) 2015-03-05 WO disclosed